Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene

Cancer Research

Volumn 54, Issue 9, 1994, Pages 2287-2291

  Fujiwara, Toshiyoshi ^a   Grimm, Elizabeth A ^b   Mukhopadhyay, Tapas ^a   Zhang, Wei Wei ^a   Owen Schaub, Laurie B ^a   Roth, Jack A ^c  

^a The University of Texas M D Anderson Cancer Center ^*

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Dept of Thorac/Cardiovasc Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CISPLATIN; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG SENSITIVITY; GENE DELETION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO CULTURE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DNA DAMAGE; DNA, NEOPLASM; DRUG RESISTANCE; GENES, P53; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028231586     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lowe, S.W. Schmitt, E.M. Smith, S.W. Osborne, B.A. and Jacks, T. p. 3 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
2. Clarke, A.R. Purdie, C.A. Harrison, D.J. Morris, R.G. Bird, C.C. Hooper, M.L. and Wyllie, A.H. Thymocyte apoptosis induced by p. 3-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
3. Fritsche, M. Haessler, C. and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p. 3 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
4. Harper, J.E. Adami, G.R. Wei, N. Keyomarsi, K. and Elledge, S.J. The p. 1 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
5. El-Deiry, W.S. Tokino, T. Velculescu, V.E. Levy, D.B. Parsons, R. Trent, J.M. Lin, D. Mercer, E. Kinzler, K.W. and Vogelstein, B. WAF1, a potential mediator of p. 3 tumor suppression. Cell, 75: 817-825, 1993.
6. Levine, A.J. Momand, J. and Finlay, C.A. The p. 3 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
7. Hollstein, M. Sidransky, D. Vogelstein, B. and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
8. Lowe, S.W. Ruley, H.E. Jacks, T. and Housman, D.E. p. 3-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
9. Takahashi, T. Nau, M.M. Chiba, I. Birrer, M.J. Rosenberg, R.K. Vinocour, M. Levitt, M. Pass, H. Gazdar, A.F. and Minna, J.D. p. 3: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
10. Zhang, W.W. Fang, X. Branch, C.D. Mazur, W. French, B.A. and Roth, J.A. Generation and identification of recombinant adenovirus by lipsome-mediated transfection and PCR analysis. Biotechniques, 15: 868-872, 1993.
11. Graham, F.L. and Prevec, L. Manipulation of adenovirus vectors. In: E.J. Murray (ed.), Methods in Molecular Biology, Gene Transfer and Expression Protocols, pp. 109-128. New Jersey: The Humana Press, Inc. 1991.
12. Gavrieli, Y. Sherman, Y. and Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501, 1992.
13. Yonish-Rouach, E. Resnitzky, D. Rotem, J. Sachs, L. Kimchi, A. and Oren, M. Wild-type p. 3 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
14. Shaw, P. Bovey, R. Tardy, S. Sahli, R. Sordat, B. and Costa, J. Induction of apoptosis by wild-type 53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
15. Ramqvist, T. Magnusson, K.P. Wang, Y. Szekeley, L. and Klein, G. Wild-type p. 3 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p. 3. Oncogene, 8: 1495-1500, 1993.
16. Cai, D.W. Mukhopadhyay, T. Liu, T. Fujiwara, T. and Roth, J.A. Stable expression of the wild-type p. 3 gene in human lung cancer cells after retrovirusmediated gene transfer. Hum. Gene Ther. 4: 617-624, 1993.
17. Fujiwara, T. Grimm, E.A. Mukhopadhyay, T. Cai, D.W. Owen-Schaub, L.B. and Roth, J.A. A retroviral wild-type p. 3 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53: 4129-4133, 1993.
18. Doyle, L.A. Mechanisms of drug resistance in human lung cancer cells. Semin. Oncol. 20: 326-337, 1993.
19. Culver, K.W. Ram, Z. Wallbridge, S. Ishii, H. Oldfield, E.H. and Blaese, R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
20. Zhan, Q. Carrier, F. and Fornace, A.J. Jr. Induction of cellular p. 3 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13: 4242-4250, 1993.
21. Tishler, R.B. Calderwood, S.K. Coleman, C.N. and Price, B.D. Increases in sequence specific DNA binding by p. 3 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53: 2212-2216, 1993.
22. Zhang, W.W. Fang, X. Mazur, W. French, B.A. Georges, R.N. and Roth, J.A. High-efficiency gene transfer and high-level expression of wild-type p. 3 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1: 1-10, 1994.